CuroNZ Wins Support From National MS Society

Monday, 14 October 2013, 10:46 am | Curonz

CuroNZ, an Auckland biotechnology start-up company developing treatments for progressive multiple sclerosis, has been awarded funding of US$ 540,000 from the National Multiple Sclerosis Society through Fast Forward to support preclinical studies needed to develop ... More >>